UAVenture Capital Fund II has backed University of Arizona spinout StimAire, which is working on neuromodulation-based treatments for conditions including obstructive sleep apnoea.
StimAire, a US-based sleep apnoea treatment developer spun out of University of Arizona, raised an undisclosed amount from UA-focused investment fund UAVenture Capital Fund yesterday.
UAVenture Capital Fund typically invests about $2m per deal in UA-linked businesses but is managed independently from the university. The cash was provided out of its second fund.
Founded in 2017, StimAire is working on a neurostimulation device for patients living with obstructive sleep apnoea, where breathing is disrupted during sleep by the…
